Find clinical trials for Melanoma in Philadelphia, PA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Melanoma trials near Philadelphia, PA, USA:
Neoadjuvant/adjuvant IDE196 (darovasertib) in patients with primary uveal melanoma...
Phase 2
Philadelphia, Pennsylvania, United States and 22 other locations
alone in participants with untreated, unresectable or metastatic melanoma. Participants randomized to the pembrolizumab monotherapy arm who ...
Phase 3
Camden, New Jersey, United States of America and 32 other locations
of using hydroxychloroquine (HCQ) in combination with nivolumab and ipilimumab or with nivolumab alone in subjects with advanced/metastatic melanoma...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States
therapy per local standard of care (SoC), best supportive care (BSC)) on protocol survivor follow up) in patients with advanced non-ocular melanoma...
Phase 2, Phase 3
Philadelphia, Pennsylvania, United States and 70 other locations
emitting therapeutic agent targeted to melanocortin sub-type 1 receptor (MC1R) is being evaluated in patients with unresectable and metastatic melanoma...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States of America and 8 other locations
safety, tolerability, and preliminary efficacy of belzupacap sarotalocan for the treatment of primary indeterminate lesions and small choroidal melanoma...
Phase 2
Philadelphia, Pennsylvania, United States and 21 other locations
efficacy of belzupacap sarotalocan (bel-sar) compared to sham control in patients with primary indeterminate lesions (IL) or small choroidal melanoma...
Phase 3
Philadelphia, Pennsylvania, United States and 37 other locations
This phase II trial studies how well nivolumab works in treating patients with stage IIB-IIC melanoma that can be removed by surgery. Monocl...
Phase 2
Philadelphia, Pennsylvania, United States and 3 other locations
Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma
This randomized phase II trial studies how well sunitinib malate or valproic acid works in preventing high-risk uveal (eye) melanoma from sp...
Phase 2
Philadelphia, Pennsylvania, United States
To evaluate the overall survival of HLA-A*0201 positive adult patients with previously untreated advanced UM receiving IMCgp100 compared to Investiga...
Phase 2
Philadelphia, Pennsylvania, United States and 55 other locations
Clinical trials
Research sites
Resources
Legal